HEADER ISOMERASE 12-DEC-02 1NF0 TITLE TRIOSEPHOSPHATE ISOMERASE IN COMPLEX WITH DHAP COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIOSEPHOSPHATE ISOMERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TIM; COMPND 5 EC: 5.3.1.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 GENE: TPI1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: JA300; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PKK223-3 KEYWDS YEAST, TRIOSEPHOSPHATE ISOMERASE, DHAP, DIHYDROXYACETONE PHOSPHATE, KEYWDS 2 MICHAELIS COMPLEX, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.JOGL,S.ROZOVSKY,A.E.MCDERMOTT,L.TONG REVDAT 5 16-AUG-23 1NF0 1 REMARK REVDAT 4 27-OCT-21 1NF0 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 1NF0 1 VERSN REVDAT 2 14-JAN-03 1NF0 1 JRNL REVDAT 1 07-JAN-03 1NF0 0 JRNL AUTH G.JOGL,S.ROZOVSKY,A.E.MCDERMOTT,L.TONG JRNL TITL OPTIMAL ALIGNMENT FOR ENZYMATIC PROTON TRANSFER: STRUCTURE JRNL TITL 2 OF THE MICHAELIS COMPLEX OF TRIOSEPHOSPHATE ISOMERASE AT JRNL TITL 3 1.2-A RESOLUTION JRNL REF PROC.NATL.ACAD.SCI.USA V. 100 50 2003 JRNL REFN ISSN 0027-8424 JRNL PMID 12509510 JRNL DOI 10.1073/PNAS.0233793100 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.209 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.213 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 6291 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 62255 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.202 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.205 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 10.200 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 5932 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 58374 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3758 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 419 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 4194.3 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 18 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 17233 REMARK 3 NUMBER OF RESTRAINTS : 16005 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 ANGLE DISTANCES (A) : 0.028 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.047 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.051 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.020 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 ANISOTROPIC SCALING APPLIED BY THE METHOD OF PARKIN, MOEZZI & HOPE, REMARK 3 J.APPL.CRYST. 28(1995) 53-56 REMARK 4 REMARK 4 1NF0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-DEC-02. REMARK 100 THE DEPOSITION ID IS D_1000017814. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JAN-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9280 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62255 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: COMO REMARK 200 SOFTWARE USED: COMO REMARK 200 STARTING MODEL: PDB ENTRY 1I45 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50MM TRIS, 50MM NACL,20% PEG 4000,30MM REMARK 280 DHAP, PH 6.8, EVAPORATION, RECRYSTALLIZATION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.62900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 80.34200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.08500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 80.34200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.62900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.08500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 49 CG - CD1 - CE1 ANGL. DEV. = -4.8 DEGREES REMARK 500 ALA A 212 CA - C - O ANGL. DEV. = 42.4 DEGREES REMARK 500 ARG A 247 NE - CZ - NH1 ANGL. DEV. = -4.0 DEGREES REMARK 500 ARG B 3 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 TYR B 67 CB - CG - CD2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ASP B 105 CB - CG - OD1 ANGL. DEV. = 6.9 DEGREES REMARK 500 TYR B 164 CB - CG - CD2 ANGL. DEV. = 4.2 DEGREES REMARK 500 TYR B 164 CB - CG - CD1 ANGL. DEV. = -4.0 DEGREES REMARK 500 TYR B 208 CB - CG - CD2 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG B 247 NE - CZ - NH1 ANGL. DEV. = -3.5 DEGREES REMARK 500 ASN B 248 CA - C - O ANGL. DEV. = -13.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 12 -153.28 53.99 REMARK 500 SER A 100 -76.21 -85.97 REMARK 500 PRO A 166 75.16 -57.41 REMARK 500 ARG B 3 107.56 -43.19 REMARK 500 LYS B 12 -148.81 50.49 REMARK 500 ASN B 35 39.30 -91.31 REMARK 500 SER B 100 -67.32 -94.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 13P A 5001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 13P B 1150 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1I45 RELATED DB: PDB REMARK 900 YEAST TRIOSEPHOSPHATE ISOMERASE (MUTANT) REMARK 900 RELATED ID: 1NEY RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE IN COMPLEX WITH DHAP DBREF 1NF0 A 2 248 UNP P00942 TPIS_YEAST 1 247 DBREF 1NF0 B 2 248 UNP P00942 TPIS_YEAST 1 247 SEQADV 1NF0 TYR A 90 UNP P00942 TRP 89 ENGINEERED MUTATION SEQADV 1NF0 PHE A 157 UNP P00942 TRP 156 ENGINEERED MUTATION SEQADV 1NF0 FTR A 168 UNP P00942 TRP 167 MODIFIED RESIDUE SEQADV 1NF0 TYR B 90 UNP P00942 TRP 89 ENGINEERED MUTATION SEQADV 1NF0 PHE B 157 UNP P00942 TRP 156 ENGINEERED MUTATION SEQADV 1NF0 FTR B 168 UNP P00942 TRP 167 MODIFIED RESIDUE SEQRES 1 A 247 ALA ARG THR PHE PHE VAL GLY GLY ASN PHE LYS LEU ASN SEQRES 2 A 247 GLY SER LYS GLN SER ILE LYS GLU ILE VAL GLU ARG LEU SEQRES 3 A 247 ASN THR ALA SER ILE PRO GLU ASN VAL GLU VAL VAL ILE SEQRES 4 A 247 CYS PRO PRO ALA THR TYR LEU ASP TYR SER VAL SER LEU SEQRES 5 A 247 VAL LYS LYS PRO GLN VAL THR VAL GLY ALA GLN ASN ALA SEQRES 6 A 247 TYR LEU LYS ALA SER GLY ALA PHE THR GLY GLU ASN SER SEQRES 7 A 247 VAL ASP GLN ILE LYS ASP VAL GLY ALA LYS TYR VAL ILE SEQRES 8 A 247 LEU GLY HIS SER GLU ARG ARG SER TYR PHE HIS GLU ASP SEQRES 9 A 247 ASP LYS PHE ILE ALA ASP LYS THR LYS PHE ALA LEU GLY SEQRES 10 A 247 GLN GLY VAL GLY VAL ILE LEU CYS ILE GLY GLU THR LEU SEQRES 11 A 247 GLU GLU LYS LYS ALA GLY LYS THR LEU ASP VAL VAL GLU SEQRES 12 A 247 ARG GLN LEU ASN ALA VAL LEU GLU GLU VAL LYS ASP PHE SEQRES 13 A 247 THR ASN VAL VAL VAL ALA TYR GLU PRO VAL FTR ALA ILE SEQRES 14 A 247 GLY THR GLY LEU ALA ALA THR PRO GLU ASP ALA GLN ASP SEQRES 15 A 247 ILE HIS ALA SER ILE ARG LYS PHE LEU ALA SER LYS LEU SEQRES 16 A 247 GLY ASP LYS ALA ALA SER GLU LEU ARG ILE LEU TYR GLY SEQRES 17 A 247 GLY SER ALA ASN GLY SER ASN ALA VAL THR PHE LYS ASP SEQRES 18 A 247 LYS ALA ASP VAL ASP GLY PHE LEU VAL GLY GLY ALA SER SEQRES 19 A 247 LEU LYS PRO GLU PHE VAL ASP ILE ILE ASN SER ARG ASN SEQRES 1 B 247 ALA ARG THR PHE PHE VAL GLY GLY ASN PHE LYS LEU ASN SEQRES 2 B 247 GLY SER LYS GLN SER ILE LYS GLU ILE VAL GLU ARG LEU SEQRES 3 B 247 ASN THR ALA SER ILE PRO GLU ASN VAL GLU VAL VAL ILE SEQRES 4 B 247 CYS PRO PRO ALA THR TYR LEU ASP TYR SER VAL SER LEU SEQRES 5 B 247 VAL LYS LYS PRO GLN VAL THR VAL GLY ALA GLN ASN ALA SEQRES 6 B 247 TYR LEU LYS ALA SER GLY ALA PHE THR GLY GLU ASN SER SEQRES 7 B 247 VAL ASP GLN ILE LYS ASP VAL GLY ALA LYS TYR VAL ILE SEQRES 8 B 247 LEU GLY HIS SER GLU ARG ARG SER TYR PHE HIS GLU ASP SEQRES 9 B 247 ASP LYS PHE ILE ALA ASP LYS THR LYS PHE ALA LEU GLY SEQRES 10 B 247 GLN GLY VAL GLY VAL ILE LEU CYS ILE GLY GLU THR LEU SEQRES 11 B 247 GLU GLU LYS LYS ALA GLY LYS THR LEU ASP VAL VAL GLU SEQRES 12 B 247 ARG GLN LEU ASN ALA VAL LEU GLU GLU VAL LYS ASP PHE SEQRES 13 B 247 THR ASN VAL VAL VAL ALA TYR GLU PRO VAL FTR ALA ILE SEQRES 14 B 247 GLY THR GLY LEU ALA ALA THR PRO GLU ASP ALA GLN ASP SEQRES 15 B 247 ILE HIS ALA SER ILE ARG LYS PHE LEU ALA SER LYS LEU SEQRES 16 B 247 GLY ASP LYS ALA ALA SER GLU LEU ARG ILE LEU TYR GLY SEQRES 17 B 247 GLY SER ALA ASN GLY SER ASN ALA VAL THR PHE LYS ASP SEQRES 18 B 247 LYS ALA ASP VAL ASP GLY PHE LEU VAL GLY GLY ALA SER SEQRES 19 B 247 LEU LYS PRO GLU PHE VAL ASP ILE ILE ASN SER ARG ASN MODRES 1NF0 FTR A 168 TRP FLUOROTRYPTOPHANE MODRES 1NF0 FTR B 168 TRP FLUOROTRYPTOPHANE HET FTR A 168 30 HET FTR B 168 15 HET 13P A5001 10 HET 13P B1150 10 HETNAM FTR FLUOROTRYPTOPHANE HETNAM 13P 1,3-DIHYDROXYACETONEPHOSPHATE FORMUL 1 FTR 2(C11 H11 F N2 O2) FORMUL 3 13P 2(C3 H7 O6 P) FORMUL 5 HOH *419(H2 O) HELIX 1 1 SER A 16 THR A 29 1 14 HELIX 2 2 PRO A 43 THR A 45 5 3 HELIX 3 3 TYR A 46 VAL A 54 1 9 HELIX 4 4 SER A 79 VAL A 86 1 8 HELIX 5 5 HIS A 95 PHE A 102 1 8 HELIX 6 6 ASP A 105 GLN A 119 1 15 HELIX 7 7 THR A 130 ALA A 136 1 7 HELIX 8 8 LYS A 138 GLU A 152 1 15 HELIX 9 9 PRO A 166 ILE A 170 5 5 HELIX 10 10 THR A 177 GLY A 197 1 21 HELIX 11 11 GLY A 197 LEU A 204 1 8 HELIX 12 12 ASN A 216 LYS A 221 5 6 HELIX 13 13 GLY A 232 PRO A 238 5 7 HELIX 14 14 GLU A 239 ASN A 245 1 7 HELIX 15 15 SER B 16 ALA B 30 1 15 HELIX 16 16 PRO B 43 THR B 45 5 3 HELIX 17 17 TYR B 46 VAL B 54 1 9 HELIX 18 18 SER B 79 VAL B 86 1 8 HELIX 19 19 HIS B 95 PHE B 102 1 8 HELIX 20 20 ASP B 105 GLN B 119 1 15 HELIX 21 21 THR B 130 ALA B 136 1 7 HELIX 22 22 LYS B 138 GLU B 152 1 15 HELIX 23 23 PRO B 166 ILE B 170 5 5 HELIX 24 24 THR B 177 GLY B 197 1 21 HELIX 25 25 GLY B 197 LEU B 204 1 8 HELIX 26 26 ASN B 216 LYS B 221 5 6 HELIX 27 27 GLY B 232 LYS B 237 5 6 HELIX 28 28 PRO B 238 ASN B 245 1 8 SHEET 1 A 9 PHE A 6 ASN A 10 0 SHEET 2 A 9 GLU A 37 CYS A 41 1 O CYS A 41 N GLY A 9 SHEET 3 A 9 VAL A 59 ALA A 63 1 O THR A 60 N VAL A 38 SHEET 4 A 9 TYR A 90 LEU A 93 1 O ILE A 92 N ALA A 63 SHEET 5 A 9 GLY A 122 ILE A 127 1 O CYS A 126 N LEU A 93 SHEET 6 A 9 VAL A 160 TYR A 164 1 O ALA A 163 N LEU A 125 SHEET 7 A 9 ILE A 206 GLY A 209 1 O LEU A 207 N VAL A 162 SHEET 8 A 9 GLY A 228 VAL A 231 1 O GLY A 228 N TYR A 208 SHEET 9 A 9 PHE A 6 ASN A 10 1 N GLY A 8 O VAL A 231 SHEET 1 B 9 PHE B 5 ASN B 10 0 SHEET 2 B 9 VAL B 36 CYS B 41 1 O CYS B 41 N GLY B 9 SHEET 3 B 9 VAL B 59 ALA B 63 1 O GLY B 62 N ILE B 40 SHEET 4 B 9 TYR B 90 LEU B 93 1 O ILE B 92 N ALA B 63 SHEET 5 B 9 GLY B 122 ILE B 127 1 O CYS B 126 N LEU B 93 SHEET 6 B 9 VAL B 160 TYR B 164 1 O VAL B 161 N LEU B 125 SHEET 7 B 9 ILE B 206 GLY B 209 1 O LEU B 207 N VAL B 162 SHEET 8 B 9 GLY B 228 VAL B 231 1 O GLY B 228 N TYR B 208 SHEET 9 B 9 PHE B 5 ASN B 10 1 N GLY B 8 O PHE B 229 LINK C AVAL A 167 N AFTR A 168 1555 1555 1.32 LINK C BVAL A 167 N BFTR A 168 1555 1555 1.33 LINK C AFTR A 168 N AALA A 169 1555 1555 1.33 LINK C BFTR A 168 N BALA A 169 1555 1555 1.32 LINK C VAL B 167 N FTR B 168 1555 1555 1.35 LINK C FTR B 168 N ALA B 169 1555 1555 1.34 SITE 1 AC1 15 ASN A 10 LYS A 12 HIS A 95 GLU A 165 SITE 2 AC1 15 ILE A 170 GLY A 171 GLY A 210 SER A 211 SITE 3 AC1 15 ALA A 212 LEU A 230 GLY A 232 GLY A 233 SITE 4 AC1 15 HOH A5026 HOH A5099 HOH A5140 SITE 1 AC2 14 ASN B 10 LYS B 12 HIS B 95 GLU B 165 SITE 2 AC2 14 ILE B 170 GLY B 171 GLY B 210 SER B 211 SITE 3 AC2 14 LEU B 230 GLY B 232 GLY B 233 HOH B1157 SITE 4 AC2 14 HOH B1182 HOH B1187 CRYST1 47.258 62.170 160.684 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021160 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016085 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006223 0.00000